Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLC

Benzer Materyaller

• RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report
  Yazar:: Christina Brzezniak, ve diğerleri
  Baskı/Yayın Bilgisi: (2016-01-01)
• RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report
  Yazar:: Brzezniak, Christina, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Partial Response to Platinum Doublets in Refractory EGFR-Positive Non-Small Cell Lung Cancer Patients after RRx-001: Evidence of Episensitization
  Yazar:: Carter, Corey A., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets
  Yazar:: Carter, Corey A., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient with a Treatment-Refractory Neuroendocrine Tumor
  Yazar:: Carter, Corey A., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)